How should a 14-year-old female with markedly elevated serum testosterone be evaluated and managed?

Evaluation and Management of Markedly Elevated Testosterone in a 14-Year-Old Female

This 14-year-old female with testosterone of 286 ng/dL requires immediate comprehensive endocrine evaluation to identify the source of hyperandrogenism, as this level is approximately 10-20 times the normal range for adolescent females and suggests either an androgen-secreting tumor, severe polycystic ovary syndrome (PCOS), or non-classical congenital adrenal hyperplasia.

Critical First Step: Verify the Laboratory Result

• Confirm the testosterone level using liquid chromatography-tandem mass spectrometry (LC-MS/MS) rather than relying solely on immunoassay, as immunoassays frequently produce falsely elevated testosterone results in females due to heterophilic antibodies and cross-reacting substances 1, 2.
• Immunoassays can give falsely high results that are unpredictable for any given sample, and this interference cannot be predicted 1.
• Recent case reports demonstrate that heterophilic antibodies can lead to unnecessary investigations, misdiagnosis, and inappropriate treatments when elevated testosterone on immunoassay doesn't match clinical findings 2.

Immediate Clinical Assessment

Evaluate for signs of virilization and hyperandrogenism:

• Assess for precocious puberty signs including early breast development, pubic/axillary hair, and accelerated growth velocity, as topical testosterone exposure can cause virilization and precocious puberty in children 3.
• Examine for hirsutism using the Ferriman-Gallwey score, looking specifically for male escutcheon pattern 3.
• Document menstrual history using a menstrual chart for at least 6 months to identify oligomenorrhea (cycles >35 days) or amenorrhea (no bleeding >6 months) 3.
• Measure waist-to-hip ratio to assess for truncal obesity (WHR >0.9), which suggests PCOS 3.
• Check for acanthosis nigricans, which may indicate insulin resistance or, in rare cases, X-linked acrogigantism 3.

Essential Diagnostic Workup

Hormonal evaluation (blood drawn between days 3-6 of menstrual cycle):

• LH and FSH levels (average of three measurements 20 minutes apart): LH/FSH ratio >2 suggests PCOS 3.
• Prolactin (morning resting level, not postictal): levels >20 μg/L warrant evaluation for pituitary adenoma or hypothyroidism 3.
• DHEAS (dehydroepiandrosterone sulfate): markedly elevated levels (>3800 ng/mL for age 20-29) suggest adrenal or ovarian tumor 3.
• Androstenedione: levels >10.0 nmol/L require evaluation for adrenal or ovarian tumor 3.
• 17-hydroxyprogesterone to screen for non-classical congenital adrenal hyperplasia 3.
• Fasting glucose and insulin with glucose/insulin ratio calculation: ratio >4 suggests insulin resistance associated with PCOS 3.

Imaging studies:

• Pelvic ultrasound (transvaginal if sexually active, otherwise transabdominal, performed days 3-9 of cycle): look for >10 peripheral cysts (2-8 mm diameter) and thickened ovarian stroma suggesting polycystic ovaries 3.
• Adrenal imaging (CT or MRI) if DHEAS is markedly elevated to exclude adrenal tumor 4.
• Consider bilateral ovarian vein sampling if imaging is inconclusive but clinical suspicion remains high for ovarian source, as this can localize ectopic testosterone production 4.

Differential Diagnosis Priority

With testosterone of 286 ng/dL, prioritize these diagnoses:

1. Androgen-secreting tumor (ovarian or adrenal): Most likely given the extreme elevation; requires urgent imaging 3, 4.
2. Severe PCOS: Prevalence is 10-25% in females with epilepsy but can occur in general population; typically presents with LH/FSH ratio >2, anovulation (progesterone <6 nmol/L mid-luteal phase), and polycystic ovaries on ultrasound 3.
3. Non-classical congenital adrenal hyperplasia: Screen with 17-hydroxyprogesterone 3.
4. Exogenous testosterone exposure: Specifically ask about household members using topical testosterone preparations, as transfer from unwashed application sites can cause virilization in children 3.

Management Approach

If tumor is identified:

• Immediate referral to pediatric endocrinology and surgical oncology for definitive management 4.
• Bilateral ovarian vein sampling may be necessary to lateralize the source before surgery 4.

If PCOS is diagnosed:

• Lifestyle modification including weight loss if BMI >25, as obesity exacerbates hyperandrogenism 3.
• Hormonal contraceptives to regulate menstrual cycles and reduce androgen production 3.
• Metformin if insulin resistance is documented (glucose/insulin ratio >4) 3.
• Monitor for long-term metabolic complications including diabetes and cardiovascular disease 3.

If exogenous testosterone exposure:

• Identify and eliminate the source of testosterone exposure 3.
• Counsel household members using topical testosterone to cover application sites with clothing after gel dries and avoid contact with unwashed areas 3.
• Reassess testosterone levels 3 months after eliminating exposure 5.

Critical Pitfalls to Avoid

• Never rely solely on immunoassay results for testosterone in females, as commercial laboratory reference ranges (often up to 95 ng/dL) are inappropriately high and miss most cases of hyperandrogenemia 6.
• Do not delay imaging when testosterone exceeds 150-200 ng/dL, as this level raises significant concern for tumor 3, 4.
• Avoid measuring testosterone randomly throughout the day; always obtain morning samples between days 3-6 of the menstrual cycle for accurate interpretation 3, 5.
• Do not prescribe testosterone therapy to this patient, as she has hyperandrogenism, not deficiency; exogenous testosterone would worsen virilization 3.